Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome

Hypertension - United States
doi 10.1161/hypertensionaha.111.189589
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Role of Plasminogen Activator Inhibitor-1 in the Metabolic Syndrome and Its Regulation

Journal of Food Research
2014English

Breast Cancer and Metabolic Syndrome Linked Through the Plasminogen Activator Inhibitor-1 Cycle

BioEssays
BiochemistryGeneticsMolecular Biology
2007English

Differential Effects of Nebivolol Versus Metoprolol on Functional Sympatholysis in Hypertensive Humans

Hypertension
Internal Medicine
2013English

Increased Concentration of Plasminogen Activator Inhibitor-1 and Fibrinogen in Individuals With Metabolic Syndrome

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2009English

Retraction: The Effects of Residual Platelets in Plasma on Plasminogen Activator Inhibitor-1 and Plasminogen Activator Inhibitor-1-Related Assays

PLoS ONE
Multidisciplinary
2018English

Plasminogen Activator Inhibitor-1 and the Circadian Clock in Metabolic Disorders

Japanese Journal of Thrombosis and Hemostasis
2008English

Species-Specific Differential Cleavage and Polyadenylation of Plasminogen Activator Inhibitor Type 1 hnRNA

Nucleic Acids Research
Genetics
1993English

The Changes of Serum Lipoprotein(a) and Plasminogen Activator Inhibitor-1 in Primary Nephrotic Syndrome

International Journal of Sciences
2015English

Changes in Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Sepsis With Organ Failure.

Nihon Kyukyu Igakukai Zasshi
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy